Express Pharma

Lonza acquires NZ-based research-focused chemical company Zelam

112

It will allow Lonza to leverage Zelam’s existing agrochemical business for registration and sales into other global regions

Lonza has acquired Zelam, a research-focused chemical company based in New Zealand, which develops and manufactures products for crop protection, specialising in fungicides, insecticides, herbicides, foliar nutrients and additives.

We see this acquisition as an excellent opportunity to further our growth strategy for agro ingredients by providing entry into new strategic markets and products that are complementary to our existing Meta business,” said Sven Abend, Chief Strategic Officer, Lonza. “It also allows Lonza to leverage Zelam’s existing agrochemical business for registration and sales into other global regions, particularly the US, EU and South America. Zelam’s unique formulated products and patented delivery systems will benefit both the agro ingredients and wood protection markets.”

- Advertisement -

Comments are closed.